Search - tctmd.com

Displaying 401 - 420 of 681

Sort: Relevancy | Date

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

News Daily News

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

December 05, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

News Conference News AHA 2013

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Yael L. Maxwell

November 19, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

Presentation TCT 2013

DES Implantation in a Patient with Atrial Fibrillation

Presenter: Roxana Mehran

October 31, 2013

Presentation TCT 2013

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

Presenter: E. Magnus Ohman

October 31, 2013

News Conference News TCT 2013

TCT Leadership Outlines the State of Intervention

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

Presentation TCT 2013

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

Presenter: Ted Feldman

October 29, 2013

Presentation TCT 2013

The Need for Screening for Atrial Fibrillation

Presenter: David Albert

October 29, 2013

Advertisement

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

DES Implantation in a Patient with Atrial Fibrillation

Case Presentation: A Patient With Atrial Fibrillation on Rivaroxaban Who Develops a STEMI

TCT Leadership Outlines the State of Intervention

Innovation in Intervention: Perspectives from Industry

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Treatment Strategies in Patients with Atrial Fibrillation and Valvular Heart Disease

The Need for Screening for Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content